While France is known as the second largest hemp producer in the world, it remains one of the less developed cannabis markets. Nevertheless with the launch of the pilot program on medical cannabis in March 2021 and the expected changes in the CBD regulation following the CJEU’s decision of November 19, 2020, more and more companies are exploring options and opportunities to enter the French market where substantial growth is expected to be seen in the coming years. The purpose of this webinar is to provide a clear overview of the current regulatory landscape in France on both medical cannabis and wellness hemp/CBD and to answer some frequently asked questions in order to provide some practical tips as to what can be done or not and what to expect in the near future.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|EU & Germany: Annual Review 2020 and Outlook 2021 by KFN+|
|cahier des charges cannabis thérapeutique (322.1 KB)||Available after Purchase|
|CJEU - Judgement of November 19, 2020 (8.3 MB)||Available after Purchase|
|EIHA Position paper on CBD Feb 2021 (308 KB)||Available after Purchase|
|INCBA Blog article - Kanavape case (484.1 KB)||Available after Purchase|
|Medical Cannabis in France - Regulatory landscape and specifications of the pilot programme (598.7 KB)||Available after Purchase|
Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.
Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.
Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.
Marie has been a partner at DELCADE since 2022 and is a member of the Healthcare & Life Sciences team. Her activity is mainly focused on regulatory aspects related to Life Sciences.
Marie advises and represents the interests of various players in the Life Sciences sector (pharmaceutical companies, medical devices, nutraceuticals, cosmetics, food supplements, biocides, veterinary drugs, etc.) at all stages of the lifecycle of their products and services. She has also developed an in-depth expertise on regulatory and legal issues related to the emerging therapeutic cannabis and wellness hemp/CBD industries.
Her expertise spans advisory work on regulatory issues (general product regulation, clinical research, market access, product advertising, compliance, industry/healthcare professionals’ relations (anti-gift and transparency rules), vigilance, etc.) and on contractual matters. She also represents her clients in litigation before civil, commercial and administrative courts and assists them in their dealings with competent authorities (ANSM, CEPS, ANSES, ANMV, DGCCRF…). Her clients include companies of all sizes: large groups, SMEs and start-ups, both French and international.
A member of the Paris and Quebec Bars, Marie holds a Master II in Healthcare Industry Law from the University of Montpellier I, as well as an Executive MBA from ESSEC-Mannheim. After starting her career in Singapore with a major pharmaceutical group, she practiced for nearly 10 years in renowned international law firms before founding her own practice in 2020. She is a frequent speaker at international seminars and conferences on regulatory issues, particularly in relation to the cannabis industry. Outside the firm, Marie is a member of the International Cannabis Bar Association (INCBA) and the French Regulatory Affairs Association (AFAR).
“They did not know it was imposible, so they did it” (Mark Twain)
Please wait ...